explor
possibl
develop
vaccin
transmiss
gastroenter
viru
tgev
infect
recombin
swinepox
viru
rspvsa
express
tgev
protect
antigen
construct
immun
respons
protect
efficaci
vaccin
vector
assess
mice
pig
model
indirect
elisa
assay
suggest
mice
vaccin
rspvsa
level
igg
tgev
enhanc
dramat
cytokin
assay
employ
result
indic
cytokin
level
rais
vaccin
rspvsa
mice
model
result
passiv
immun
protect
test
new
born
piglet
demonstr
recombin
livevector
vaccin
rspvsa
could
protect
piglet
spv
infect
signific
clinic
symptom
rspvsa
treatment
group
experi
data
suggest
novel
recombin
swinepox
viru
potenti
vaccin
tgev
infect
transmiss
gastroenter
viru
tgev
member
coronavirida
etiolog
agent
transmiss
gastroenter
although
viru
capabl
infect
swine
age
suckl
piglet
suscept
mortal
rate
tgev
pleomorph
envelop
viru
contain
positivestrand
rna
genom
four
structur
protein
spike
protein
integr
membran
protein
minor
envelop
e
protein
nucleocapsid
n
protein
among
spike
protein
one
key
structur
membran
protein
coronavirus
attract
target
gener
neutral
antibodi
viru
due
critic
role
play
host
cell
invas
precis
protein
mediat
attach
viru
particl
target
via
bind
specif
receptor
n
terminu
protein
four
antigen
site
b
c
shown
involv
stimul
neutral
antibodi
fig
previou
studi
determin
site
fulli
depend
glycosyl
proper
fold
predominantli
respons
stimul
neutral
host
antibodi
spv
natur
mild
attenu
viru
wide
appli
vaccin
given
poxvirusvector
prevent
great
deal
import
diseas
human
anim
surpris
mani
vector
licens
use
extens
addit
spv
safe
vaccin
vector
risk
crossspeci
infect
therefor
biolog
clinic
practic
spv
regard
appropri
promis
veterinari
vaccin
swine
owe
abil
effect
express
foreign
gene
larg
packag
capac
recombin
dna
low
cost
deliveri
specif
host
restrict
potenti
valu
spv
live
vector
vaccin
studi
extens
spv
abl
pack
larg
amount
recombin
dna
induc
appropri
immun
respons
vivo
promis
candid
develop
recombin
vaccin
yet
pig
known
host
swinepox
viru
therefor
may
use
develop
safe
vaccin
clinic
applic
studi
construct
recombin
swinepox
viru
express
sa
epitop
protein
tgev
character
recombin
viru
replic
express
protein
cell
investig
potenti
approach
use
vaccin
pig
tge
type
cultur
collect
swine
transmiss
gastroenter
viru
tgev
china
strain
shxb
purchas
jiangsu
academi
agricultur
scienc
titer
determin
pfuml
st
cell
tgev
convalesc
posit
serum
purchas
jiangsu
academi
agricultur
scienc
neutral
antibodi
use
dilut
swinepox
viru
vector
gener
previous
two
primer
cgggatcctta
use
amplifi
sa
gene
bp
tgev
genom
insert
plasmid
construct
subsequ
recombin
swinepox
viru
rspvsa
gener
homolog
recombin
wtspv
previous
describ
pcr
indirect
immunofluoresc
employ
analyz
sa
gene
express
express
protein
replic
capac
genet
stabil
rspvsa
also
evalu
gener
screen
recombin
swinepox
viru
assay
perform
describ
previous
subconflu
cultur
cell
infect
wtspv
moi
h
subsequ
transfect
g
plasmid
use
exfect
tm
transfect
reagent
vazym
biotech
co
ltd
h
cell
harvest
lyse
five
round
freez
thaw
subsequ
lysat
use
infect
cell
grown
plate
purif
recombin
virus
ml
medium
lmp
agaros
dingguo
beij
china
ad
well
incub
continu
five
day
plaqu
becam
visibl
light
microscop
day
second
overlay
medium
contain
xgal
ad
plaqu
resuspend
ml
medium
fb
plaqu
isol
repeat
round
plaqu
given
well
stain
blue
recombin
spv
bear
sa
tgev
design
rspvsa
rspvsa
genom
dna
cell
infect
rspvsa
extract
sdsproteas
kphenol
util
wtspv
genom
dna
cell
infect
wtspv
neg
control
pcr
perform
min
c
follow
cycl
min
c
min
c
min
c
amplif
perform
dna
polymeras
promega
shanghai
china
use
primer
indirect
immunofluoresc
assay
ifa
perform
describ
previous
cell
grown
plate
infect
wtspv
rspvsa
pfuml
per
well
pbstreat
cell
use
neg
control
h
postinfect
cell
wash
three
time
pbst
fix
cold
methanol
min
c
cell
wash
three
time
pbst
block
pbst
bsa
prepar
incub
h
c
tgev
convalesc
posit
serum
dilut
buffer
pbst
bsa
three
wash
pbst
cell
treat
rhodamineconjug
secondari
antibodi
staphylococc
protein
arhod
boshid
wuhan
china
dilut
dilut
pb
min
c
final
wash
pb
well
examin
fluoresc
microscopi
zeiss
germani
nine
sixweekold
balbc
mice
randomli
divid
three
group
mice
per
group
immun
three
time
day
rspvsa
pfuml
ml
pb
wtspv
pfuml
ml
pb
control
group
inject
pb
eight
onemonthold
swine
larg
white
randomli
divid
four
group
pig
per
group
immun
twice
day
infecti
rspvsa
pfuml
ml
pb
inactivatedtgev
pfuml
ml
pb
wtspv
pfuml
ml
pb
pb
time
via
three
rout
oral
nasal
intraperiton
serum
collect
day
last
immun
twelv
onedayold
pig
randomli
divid
four
group
passiv
immun
experi
pig
per
group
high
titer
antibodi
collect
piglet
follow
first
immun
mice
swine
serum
incub
c
min
complement
inactiv
experiment
protocol
involv
mice
swine
approv
laboratori
anim
monitor
committe
jiangsu
provinc
cell
monolay
infect
wtspv
rspvsa
moi
incub
h
c
extract
repres
approxim
cell
electrophores
polyacrylamid
gel
separ
protein
transfer
onto
pvdf
membran
h
transfer
membran
block
skim
milk
phosphat
buffer
salin
pbst
overnight
c
membran
incub
swine
convalesc
serum
dilut
contain
tgev
h
c
wash
three
time
pbst
immunodetect
perform
staphylococc
protein
ahrp
c
follow
secondari
antibodi
probe
membran
wash
four
time
pbst
membran
develop
diaminobenzidin
substrat
optim
color
develop
observ
serum
collect
mice
pig
detect
tgevspecif
antibodi
indirect
elisa
purifi
tgev
resuspend
l
pb
ph
use
best
titer
viru
coat
plate
determin
titrat
sampl
incub
overnight
c
incub
follow
three
pbst
wash
block
skim
milk
pbst
c
h
serum
sampl
serial
dilut
incub
c
h
sampl
set
time
divid
three
group
tgev
posit
serum
neg
control
serum
spv
posit
serum
blank
control
without
serum
three
pbst
wash
horseradish
peroxidas
hrp
conjug
goat
antispa
igg
dilut
pbst
signalway
antibodi
ad
test
well
plate
incub
room
temperatur
dark
min
wash
three
time
pbst
tmb
microwel
peroxidas
substrat
system
tiangen
use
develop
reaction
sampl
develop
min
reaction
termin
sulphur
acid
assay
perform
duplic
micropl
reader
biorad
use
measur
reaction
product
absorb
nm
evalu
cellular
immun
perform
detect
level
three
mice
sacrif
day
first
inocul
wtspv
pfuml
ml
pb
rspvsa
pfuml
ml
mous
spleen
remov
asept
splenocyt
isol
count
dilut
densiti
l
evenli
separ
cell
aliquot
plate
lwell
lwell
dmem
tcid
l
tgev
ad
well
h
incub
supernat
collect
mrna
probe
rtqpcr
rel
describ
previous
assay
neutral
antibodi
perform
describ
previous
explor
whether
mice
swine
gener
tgev
neutral
antibodi
serum
pb
wtspv
inactivatedtgev
rspvsa
treat
mice
pig
collect
day
postprimari
immun
dilut
l
volum
sera
mix
equal
volum
tcid
ml
tgev
incub
c
h
incub
util
sera
treat
virus
infect
st
cell
plate
overlaid
cell
agar
c
co
atmospher
cell
monitor
daili
three
day
detect
tgevspecif
cpe
virul
tgev
strain
shxb
pfuml
ml
mix
ml
porcin
antiserum
induc
recombin
rspvsa
inactiv
tgev
pb
incub
c
min
administ
use
gastric
tube
swine
born
tgevseroneg
sow
inocul
anim
fed
three
time
per
day
formula
newborn
contain
ml
antiserum
three
day
follow
viral
infect
small
intestin
tissu
collect
newborn
pig
section
histolog
microstructur
characterist
analyz
microscop
olympu
philippin
data
analyz
use
oneway
anova
valu
p
consid
signific
analys
recombin
viru
confirm
presenc
sa
gene
two
specif
primer
design
amplifi
insert
sa
gene
gene
encod
neutral
antigen
epitop
tgev
kb
fragment
specif
fragment
detect
spvsa
shown
fig
recombin
spvsa
also
confirm
observ
blue
foci
plaqu
assay
rspvsa
wtspv
determin
approxim
pfuml
ml
shown
fig
ifa
demonstr
express
epitop
protein
present
infect
cell
western
blot
analysi
show
specif
band
target
protein
size
kda
cell
lysat
infect
rspvsa
fig
kda
molecular
weight
consist
predict
size
sa
protein
tgev
accord
data
suggest
epitop
protein
express
effici
rspvsa
viru
fig
monitor
sspecif
antibodi
titer
mice
vaccin
rspvsa
elisa
use
initi
boost
day
postvaccin
saspecif
antibodi
titer
increas
gradual
mice
fig
antibodi
titer
rspvsaimmun
mice
higher
alltim
point
postvaccin
p
n
compar
wtspv
pbstreat
mice
pn
valu
posit
group
greater
persist
high
level
neutral
antibodi
fig
detect
rspvsa
group
mean
titer
day
postinocul
mice
vaccin
wtspv
rspvsa
day
postinocul
fig
qpcr
result
show
distinct
variat
wtspv
rspvsa
treatment
group
rel
quantiti
normal
betaactin
mrna
rspvsa
time
higher
compar
wtspv
mrna
level
increas
fold
rspvsa
compar
wtspv
concentr
rspvsavaccin
mice
significantli
higher
control
group
result
indic
rspvsa
induc
cytokin
respons
cellular
immun
vaccin
procedur
sever
pox
could
observ
around
inject
posit
five
day
postinocul
rspvsa
wtspv
treatment
group
respect
observ
inactivatedtgev
pb
treatment
group
symptom
could
disappear
spontan
follow
day
pig
develop
symptom
fever
sever
inflamm
spiritu
condit
appetit
treatment
group
consid
good
two
group
pig
recov
day
group
pig
maintain
rectal
temperatur
c
experi
reveal
vaccin
rspvsa
wtspv
well
toler
pig
rspvsa
induc
moder
level
tgevspecif
igg
shown
fig
persist
high
level
tgevspecif
neutral
antibodi
shown
fig
second
boost
led
level
tgevspecif
neutral
antibodi
persist
high
level
neutral
antibodi
detect
rspvsa
group
mean
titer
swine
p
n
newborn
piglet
differ
group
fed
mixtur
tgev
correspond
sera
pig
vaccin
pb
wtspv
inactivatedtgev
rspvsa
pb
wtspv
treatment
group
develop
sever
diarrhea
symptom
significantli
lose
weight
appetit
mortal
rate
day
meanwhil
inactivatedtgev
rspvsa
treatment
group
obviou
clinic
symptom
moral
rate
observ
fig
tabl
sacrif
piglet
small
intestin
tissu
differ
group
use
patholog
examin
histolog
sampl
pb
wtspv
treatment
group
show
promin
histopatholog
chang
small
intestin
character
seriou
fractur
small
intestin
mucosa
epitheli
expans
vacuolar
degener
necrosi
shed
lamina
propria
congest
edema
hemorrhag
patholog
chang
observ
examin
sampl
inactivatedtgev
rspvsa
treatment
group
result
indic
rspvsa
inocul
provid
complet
protect
passiv
immun
tgev
challeng
pig
fig
present
studi
engin
swinepox
viru
express
epitop
tgev
protein
data
show
recombin
viru
abl
induc
strong
immun
respons
antigen
tgev
mice
pig
also
safeti
degre
protect
efficaci
virul
homolog
tgev
infect
pig
tradit
way
protect
swine
tgev
infect
immun
pregnant
sow
inactiv
attenu
vaccin
result
product
secretori
iga
colostrum
despit
protect
secretori
iga
offer
piglet
method
provid
protect
cessat
breastfeed
furthermor
inactiv
attenu
viral
vaccin
still
maintain
abil
develop
viral
toxic
current
variou
potenti
vaccin
tgev
mani
present
certain
challeng
difficulti
vaccin
process
high
product
cost
low
immunogen
biolog
risk
carcinogen
result
experi
indic
rspvsa
vaccin
promis
candid
safeti
immunogen
respect
howev
notic
aliv
viral
vector
vaccin
possibl
spv
per
se
would
interfer
vaccin
evalu
possibl
randomli
sampl
pig
sera
test
via
agaros
gel
diffus
assay
result
show
spv
posit
rate
around
moreov
report
spv
epidem
recent
year
thu
togeth
gel
diffus
assay
interf
spv
per
se
could
consid
minimum
first
time
gener
recombin
spv
express
neutral
epitop
epitop
protein
tgev
verifi
sa
express
effici
system
antigen
induc
neutral
antibodi
tgev
st
cell
potenti
strong
cytokin
respons
mous
model
result
suggest
rspvsa
induc
humor
cellular
immun
respons
effect
effici
given
cell
secret
appar
cell
play
import
role
antiintracellular
pathogen
infect
cell
studi
secret
like
cell
abl
effect
stimul
b
cell
prolifer
henc
igg
ige
antibodi
product
relev
humor
immun
defin
repres
cytokin
secretori
capac
respect
result
indic
hand
cytokin
level
increas
dramat
due
immatur
immun
system
matern
antibodi
breast
milk
account
immun
defens
abil
piglet
base
feasibl
relev
publish
paper
decid
mimic
breast
milk
femal
pig
mix
antiserum
gener
vaccin
day
old
piglet
spvsa
normal
cow
milk
use
passiv
immun
protect
test
old
piglet
studi
recombin
spv
vector
capabl
protect
neonat
piglet
mortal
sever
diseas
challeng
viru
rspvsa
vector
induc
high
titer
antibodi
swine
howev
worth
note
rspvsa
may
enhanc
antitgev
antibodi
titer
swine
well
antispv
antibodi
like
affect
immun
effici
respect
clinic
valu
imper
studi
multival
vaccin
summar
first
report
spv
use
live
vector
vaccin
express
sa
protein
tgev
determin
bcell
also
tcell
induc
success
thu
rspvsa
provid
thorough
protect
virul
tgev
challeng
swine
lastli
data
indic
rspvsa
promis
vaccin
prevent
tgev
infect
